Modernizing DCT With AI
Veridix is modernizing DCT by incorporating AI and automation into the core processes used to conduct remote and hybrid clinical trials. Many aspects of DCTs benefit from modernization including:
Identifying patients outside of traditional trial sites
Automating generation of reporting
Monitoring sites and patients to improve engagement

Telehealth in Clinical Trials
Reduce patient burden – turn scheduled visits into virtual visits, with video calls between site staff and patients from their patient portal in a secure and documented manner. Telehealth is embedded in the site workflow to enable seamless assessment navigation and data capturing.

eCOA/ePRO
Improve data quality, compliance, and patient experience with a modern, intuitive ePRO (electronic patient-reported outcomes) solution. Advantage eClinical ePRO enables fully configurable alerts, notifications, real time data access and a seamless experience for trial patients from anywhere on any device, including BYOD.

Patient Engagement
Reminders can be configured for all trial purposes, including visits, tasks, and medication adherence. Facilitate study resources and communication of other information relevant to patients – surveys, health information, etc. – through a seamless patient portal.
eConsent

Provide patients with clear and easy-to-understand clinical trial information, and the flexibility to review at the pace and in a setting convenient to them, so they are truly informed when making the decision to participate. Flexible solution to support fully virtual eConsent, electronic consent in person at site, or wet signature paper consent form.
Direct-to-Patient (DtP) Shipment Tracking

Manage the shipment of clinical trial supplies directly to and from a patient’s home, including tracking and delivery of patient-collected specimens to a clinic or laboratory.
Latest Resources
Fact Sheet

DCT Factsheet
Request a Meeting
Learn more about our cloud-based suite of applications for study design, data capture, randomization and reporting.